Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients aged of 70 years old and more~* Parkinson's disease~Exclusion Criteria:~* Opposition to participate in this trial~* Patient under a measure of legal protection~* Absence of affiliation to social security or universal health coverage (CMU)

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Exposed patients (Type: None): Patients treated for Parkinson's disease with a cumulative dose of L-DOPA above the 59th percentile of the population
- Non exposed patients (Type: None): Patients treated for Parkinson's disease with a cumulative dose of L-DOPA below the 41th percentile of the population

Based on this trial design, predict the completion outcome and termination type (if applicable).